Overactivation of Ras signaling pathway in CD133+ MPNST cells

Emma Borrego-Diaz, Kaoru Terai, Kristina Lialyte, Amanda L. Wise, Tuba Esfandyari, Fariba Behbod, Victor F. Mautner, Melanie Spyra, Sarah Taylor, Luis F. Parada, Meena Upadhyaya, Faris Farassati

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) are believed to be the regenerative pool of cells responsible for repopulating tumors. Gaining knowledge about the signaling characteristics of CSCs is important for understanding the biology of tumors and developing novel anti-cancer therapies. We have identified a subpopulation of cells positive for CD133 (a CSC marker) from human primary malignant peripheral nerve sheath tumor (MPNST) cells which were absent in non-malignant Schwann cells. CD133 was also found to be expressed in human tissue samples and mouse MPNST cells. CD133? cells were capable of forming spheres in non-adherent/serum-free conditions. The activation levels of Ras and its downstream effectors such as ERK, JNK, PI3K, p38K, and RalA were significantly increased in this population. Moreover, the CD133? cells showed enhanced invasiveness which was linked to the increased expression of b-Catenin and Snail, two important proteins involved in the epithelial to mesenchymal transition, and Paxilin, a focal adhesion protein. Among other important characteristics of the CD133? population, endoplasmic reticulum stress marker IRE1a was decreased, implying the potential sensitivity of CD133? to the accumulation of unfolded proteins. Apoptotic indicators seemed to be unchanged in CD133? cells when compared to the wild (unsorted) cells. Finally, in order to test the possibility of targeting CD133? MPNST cells with Ras pathway pharmacological inhibitors, we exposed these cells to an ERK inhibitor. The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133? cells supporting previous studies observing enhanced chemoresistance of these cells.

Original languageEnglish (US)
Pages (from-to)423-434
Number of pages12
JournalJournal of Neuro-Oncology
Volume108
Issue number3
DOIs
StatePublished - Jul 2012

Fingerprint

Neurilemmoma
Neoplastic Stem Cells
Population
Catenins
Neoplasms
Protein Unfolding
Endoplasmic Reticulum Stress
Focal Adhesions
Epithelial-Mesenchymal Transition
Schwann Cells
Phosphatidylinositol 3-Kinases
Proteins
Pharmacology

Keywords

  • Cancer stem cells
  • CD133
  • Malignant peripheral nerve sheath tumor
  • Ral
  • Ras
  • Tumor-initiating cells

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Borrego-Diaz, E., Terai, K., Lialyte, K., Wise, A. L., Esfandyari, T., Behbod, F., ... Farassati, F. (2012). Overactivation of Ras signaling pathway in CD133+ MPNST cells. Journal of Neuro-Oncology, 108(3), 423-434. https://doi.org/10.1007/s11060-012-0852-1

Overactivation of Ras signaling pathway in CD133+ MPNST cells. / Borrego-Diaz, Emma; Terai, Kaoru; Lialyte, Kristina; Wise, Amanda L.; Esfandyari, Tuba; Behbod, Fariba; Mautner, Victor F.; Spyra, Melanie; Taylor, Sarah; Parada, Luis F.; Upadhyaya, Meena; Farassati, Faris.

In: Journal of Neuro-Oncology, Vol. 108, No. 3, 07.2012, p. 423-434.

Research output: Contribution to journalArticle

Borrego-Diaz, E, Terai, K, Lialyte, K, Wise, AL, Esfandyari, T, Behbod, F, Mautner, VF, Spyra, M, Taylor, S, Parada, LF, Upadhyaya, M & Farassati, F 2012, 'Overactivation of Ras signaling pathway in CD133+ MPNST cells', Journal of Neuro-Oncology, vol. 108, no. 3, pp. 423-434. https://doi.org/10.1007/s11060-012-0852-1
Borrego-Diaz E, Terai K, Lialyte K, Wise AL, Esfandyari T, Behbod F et al. Overactivation of Ras signaling pathway in CD133+ MPNST cells. Journal of Neuro-Oncology. 2012 Jul;108(3):423-434. https://doi.org/10.1007/s11060-012-0852-1
Borrego-Diaz, Emma ; Terai, Kaoru ; Lialyte, Kristina ; Wise, Amanda L. ; Esfandyari, Tuba ; Behbod, Fariba ; Mautner, Victor F. ; Spyra, Melanie ; Taylor, Sarah ; Parada, Luis F. ; Upadhyaya, Meena ; Farassati, Faris. / Overactivation of Ras signaling pathway in CD133+ MPNST cells. In: Journal of Neuro-Oncology. 2012 ; Vol. 108, No. 3. pp. 423-434.
@article{666b66b9cf7e4745863adc00a232063b,
title = "Overactivation of Ras signaling pathway in CD133+ MPNST cells",
abstract = "Cancer stem cells (CSCs) are believed to be the regenerative pool of cells responsible for repopulating tumors. Gaining knowledge about the signaling characteristics of CSCs is important for understanding the biology of tumors and developing novel anti-cancer therapies. We have identified a subpopulation of cells positive for CD133 (a CSC marker) from human primary malignant peripheral nerve sheath tumor (MPNST) cells which were absent in non-malignant Schwann cells. CD133 was also found to be expressed in human tissue samples and mouse MPNST cells. CD133? cells were capable of forming spheres in non-adherent/serum-free conditions. The activation levels of Ras and its downstream effectors such as ERK, JNK, PI3K, p38K, and RalA were significantly increased in this population. Moreover, the CD133? cells showed enhanced invasiveness which was linked to the increased expression of b-Catenin and Snail, two important proteins involved in the epithelial to mesenchymal transition, and Paxilin, a focal adhesion protein. Among other important characteristics of the CD133? population, endoplasmic reticulum stress marker IRE1a was decreased, implying the potential sensitivity of CD133? to the accumulation of unfolded proteins. Apoptotic indicators seemed to be unchanged in CD133? cells when compared to the wild (unsorted) cells. Finally, in order to test the possibility of targeting CD133? MPNST cells with Ras pathway pharmacological inhibitors, we exposed these cells to an ERK inhibitor. The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133? cells supporting previous studies observing enhanced chemoresistance of these cells.",
keywords = "Cancer stem cells, CD133, Malignant peripheral nerve sheath tumor, Ral, Ras, Tumor-initiating cells",
author = "Emma Borrego-Diaz and Kaoru Terai and Kristina Lialyte and Wise, {Amanda L.} and Tuba Esfandyari and Fariba Behbod and Mautner, {Victor F.} and Melanie Spyra and Sarah Taylor and Parada, {Luis F.} and Meena Upadhyaya and Faris Farassati",
year = "2012",
month = "7",
doi = "10.1007/s11060-012-0852-1",
language = "English (US)",
volume = "108",
pages = "423--434",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Overactivation of Ras signaling pathway in CD133+ MPNST cells

AU - Borrego-Diaz, Emma

AU - Terai, Kaoru

AU - Lialyte, Kristina

AU - Wise, Amanda L.

AU - Esfandyari, Tuba

AU - Behbod, Fariba

AU - Mautner, Victor F.

AU - Spyra, Melanie

AU - Taylor, Sarah

AU - Parada, Luis F.

AU - Upadhyaya, Meena

AU - Farassati, Faris

PY - 2012/7

Y1 - 2012/7

N2 - Cancer stem cells (CSCs) are believed to be the regenerative pool of cells responsible for repopulating tumors. Gaining knowledge about the signaling characteristics of CSCs is important for understanding the biology of tumors and developing novel anti-cancer therapies. We have identified a subpopulation of cells positive for CD133 (a CSC marker) from human primary malignant peripheral nerve sheath tumor (MPNST) cells which were absent in non-malignant Schwann cells. CD133 was also found to be expressed in human tissue samples and mouse MPNST cells. CD133? cells were capable of forming spheres in non-adherent/serum-free conditions. The activation levels of Ras and its downstream effectors such as ERK, JNK, PI3K, p38K, and RalA were significantly increased in this population. Moreover, the CD133? cells showed enhanced invasiveness which was linked to the increased expression of b-Catenin and Snail, two important proteins involved in the epithelial to mesenchymal transition, and Paxilin, a focal adhesion protein. Among other important characteristics of the CD133? population, endoplasmic reticulum stress marker IRE1a was decreased, implying the potential sensitivity of CD133? to the accumulation of unfolded proteins. Apoptotic indicators seemed to be unchanged in CD133? cells when compared to the wild (unsorted) cells. Finally, in order to test the possibility of targeting CD133? MPNST cells with Ras pathway pharmacological inhibitors, we exposed these cells to an ERK inhibitor. The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133? cells supporting previous studies observing enhanced chemoresistance of these cells.

AB - Cancer stem cells (CSCs) are believed to be the regenerative pool of cells responsible for repopulating tumors. Gaining knowledge about the signaling characteristics of CSCs is important for understanding the biology of tumors and developing novel anti-cancer therapies. We have identified a subpopulation of cells positive for CD133 (a CSC marker) from human primary malignant peripheral nerve sheath tumor (MPNST) cells which were absent in non-malignant Schwann cells. CD133 was also found to be expressed in human tissue samples and mouse MPNST cells. CD133? cells were capable of forming spheres in non-adherent/serum-free conditions. The activation levels of Ras and its downstream effectors such as ERK, JNK, PI3K, p38K, and RalA were significantly increased in this population. Moreover, the CD133? cells showed enhanced invasiveness which was linked to the increased expression of b-Catenin and Snail, two important proteins involved in the epithelial to mesenchymal transition, and Paxilin, a focal adhesion protein. Among other important characteristics of the CD133? population, endoplasmic reticulum stress marker IRE1a was decreased, implying the potential sensitivity of CD133? to the accumulation of unfolded proteins. Apoptotic indicators seemed to be unchanged in CD133? cells when compared to the wild (unsorted) cells. Finally, in order to test the possibility of targeting CD133? MPNST cells with Ras pathway pharmacological inhibitors, we exposed these cells to an ERK inhibitor. The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133? cells supporting previous studies observing enhanced chemoresistance of these cells.

KW - Cancer stem cells

KW - CD133

KW - Malignant peripheral nerve sheath tumor

KW - Ral

KW - Ras

KW - Tumor-initiating cells

UR - http://www.scopus.com/inward/record.url?scp=84864060471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864060471&partnerID=8YFLogxK

U2 - 10.1007/s11060-012-0852-1

DO - 10.1007/s11060-012-0852-1

M3 - Article

C2 - 22484909

AN - SCOPUS:84864060471

VL - 108

SP - 423

EP - 434

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -